Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Hospitals

 

Covid: The double whammy – who will be left standing?

In a recent paper on the medtech outlook for Europe, UBS, looked at how Singapore and Toronto bounced back from pandemics. Pent up demand simply led to double growth rates the year after. But Covid is two things: a pandemic coupled to a steep recession, almost certainly worse than 2008. We look at what this means for a sector where private equity has often geared up to the hilt.

Interview: Tony Veverka, CEO, Transform

HBI talks to Tony Veverka, CEO of cosmetic surgery specialist Transform Hospital Group, about his business, and the market pre-and (speculatively) post-COVID.

COVID-19 may force re-think of German hospital ‘rationalisation’

Germany's arguably excessive hospital capacity, much of it in small regional hospitals, has proven an invaluable asset during coronavirus. A senior hospital executive tells us this may change policy conversations of the last 2-3 years around the need to trim the sector down, though paradoxically the crisis may also send the sector further into deficit.

Brazil looking to learn from Europe’s COVID care home crisis

Care homes in Brazil are looking to avoid the mistakes made in Europe, and are lobbying government to ensure there are medical facilities available for elderly patients showing signs of COVID-19. If isolation within care homes in Europe didn't work, and it clearly hasn't, it will be impossible in Brazil they say.

After the peak: Chinese hospitals fear economic downturn

China's private hospital groups appear to have survived the lockdown with limited financial intervention from the government, but concern is growing, particularly at the premium end of the market, that a long-term economic downturn will push demand away from private care. HBI talks to a Shanghai-based consultant to find out more. 

COVID-19: Lockdowns and travel restrictions hit emerging market hospitals

Nationwide lockdowns and travel restrictions are hitting private hospital chains in India, Turkey and Southeast Asia, where the biggest groups garner 10-15% of revenues from international patients. HBI talks to an India-based source to find out more and looks at how operators are faring.

Find Us